Article | January 11, 2023

3 Ways To Adopt A Quality Management Maturity Model In Drug Manufacturing

By Ave Anderegg

Quality Management GettyImages-1336716297

Trends in quality management show that supply chain disruptions continue to pose a threat to pharmaceutical companies and have a far-reaching impact on the entire healthcare ecosystem. The U.S. Food and Drug Administration (FDA) is keenly aware of this impact and is intent on remediating it.

The FDA’s Center for Drug Evaluation and Research (CDER) released a white paper revisiting a proposed public quality management maturity (QMM) rating system that outlined their desire for pharmaceutical companies to operate on a QMM model. The objective of quality management maturity (QMM) is to elevate quality beyond the base level of current good manufacturing practices. This can be accomplished readily by adopting a digital quality management software solution. Explore three practical paths to pharma QMM and the key benefits of using a digital pharma QMS.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online